Works by Blagbrough, Ian S.


Results: 21
    1
    2
    3
    4

    Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.

    Published in:
    Addiction, 2022, v. 117, n. 11, p. 2899, doi. 10.1111/add.15967
    By:
    • Craft, Sam;
    • Dunn, Michael;
    • Vidler, Dan;
    • Officer, Jane;
    • Blagbrough, Ian S.;
    • Pudney, Christopher R.;
    • Henderson, Graeme;
    • Abouzeid, Ahmed;
    • Dargan, Paul I.;
    • Eddleston, Michael;
    • Cooper, Jamie;
    • Hill, Simon L.;
    • Roper, Clair;
    • Freeman, Tom P.;
    • Thomas, Simon H. L.
    Publication type:
    Article
    5
    6
    7

    Synthetic cannabinoid receptor agonists are monoamine oxidase‐A selective inhibitors.

    Published in:
    FEBS Journal, 2023, v. 290, n. 12, p. 3243, doi. 10.1111/febs.16741
    By:
    • Hindson, Sarah A.;
    • Andrews, Rachael C.;
    • Danson, Michael J.;
    • van der Kamp, Marc W.;
    • Manley, Amy E.;
    • Sutcliffe, Oliver B.;
    • Haines, Tom S. F.;
    • Freeman, Tom P.;
    • Scott, Jennifer;
    • Husbands, Stephen M.;
    • Blagbrough, Ian S.;
    • Anderson, J. L. Ross;
    • Carbery, David R.;
    • Pudney, Christopher R.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21